Our vision
Moving diagnostic frontiers in dermatology.
Our mission
We build leading innovative molecular diagnostic solutions at scale and at point of need for diagnostic laboratories, dermatologists and academic and pharmaceutical research organizations. With our quick, precise and automated tests, we enable skin experts to recommend the best treatments for human skin health.
Company history
Dermagnostix was founded as a spin-off from the Hahn-Schickard Institut in Freiburg, the Helmholtz Zentrum München (HMGU) and TU Munich, after decades of top-level research in dermatology, immunology, bioinformatics and microfluidics. We are located in Southern Germany (Freiburg).
Game-changing modern therapies have evolved the treatment of inflammatory disease and skin cancer. Diagnostics have not kept pace with these therapeutic advances. Dermagnostix closes this gap bringing objective molecular results directly to the physician.
Management
Board
Professor and Chair in Dermatology,
Co-Founder
Friedrich Hecker
Non-Executive Board Member, Senior Advisor, Startup Investor.
Martin Klässner
Serial Entrepreneur and Investor with Software-as-a-Service background in the domains Energy, Medical and Robotics.
Prof. Helmut Laaff, MD
Dermatopathologist, Owner IDPM Freiburg Group, Professor Department Chemistry and Pharmacy University Freiburg.
Translational Research Inflammatory Skin Diseases, University Medical Center Hamburg; Medical Director JeruCON GmbH.
Prof. Roland Zengerle, PhD
Professor for MEMS applications, University of Freiburg; Executive Board member of Hahn-Schickard.
Dermagnostix, a spin-off company of
Awards
2024
2022
2022
2021
2020
2020
2020
2020
2020
2020
2019
2018
Certificate
Since November 2022 Dermagnostix is officially EN ISO 13485 certified.
View certificate
Support programme INVEST
Dermagnostix was granted a notice of eligibility by BAFA as part of the INVEST funding measure of the Federal Ministry of Economics and Climate Protection to subsidize venture capital from private investors for young innovative companies.
Learn more
Member of
